Free Trial
→ The roadshow starts Monday. This stock isn't ready. (From Behind the Markets) (Ad)tc pixel Free CYRX Stock Alerts

CryoPort (CYRX) Financials

CryoPort logo
$14.62 +0.24 (+1.67%)
Closing price 04:00 PM Eastern
Extended Trading
$14.79 +0.17 (+1.16%)
As of 06:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for CryoPort

Annual Income Statements for CryoPort

This table shows CryoPort's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -12 -13 -7.90 -9.56 -18 -75 -284 -45 -108 -123 70
Consolidated Net Income / (Loss)		 -7.03 -13 -7.90 -9.56 -18 -33 -276 -37 -100 -115 78
Net Income / (Loss) Continuing Operations		 -7.03 -13 -7.90 -9.56 -18 -33 -276 -37 -85 -105 -34
Total Pre-Tax Income 		-7.03 -13 -7.89 -9.54 -18 -33 -274 -35 -84 -104 -32
Total Operating Income		 -5.59 -8.77 -7.89 -8.64 -18 -30 -18 -32 -101 -122 -37
Total Gross Profit		 1.17 3.10 5.97 10 17 36 97 104 75 70 83
Total Revenue		 3.94 7.68 12 20 34 79 223 237 169 157 176
Total Cost of Revenue		 2.77 4.58 5.99 9.39 17 42 126 133 93 87 93
Operating Cost of Revenue		 2.77 4.58 5.99 9.39 17 42 126 133 93 87 93
Total Operating Expenses		 6.76 12 14 19 35 66 114 136 176 191 120
Selling, General & Admin Expense		 3.50 6.45 7.42 9.80 31 57 98 120 108 110 103
Research & Development Expense		 0.35 0.60 1.21 1.84 3.74 9.48 17 16 18 18 17
Impairment Charge		 - - - - - - 0.00 0.00 50 64 0.00
Total Other Income / (Expense), net		 -1.43 -4.34 -0.00 -0.89 -0.60 -2.73 -256 -3.19 16 17 4.64
Interest Expense		 1.43 0.14 0.02 0.07 1.37 2.56 256 6.14 -0.10 -15 2.36
Interest & Investment Income		 - - - - 0.58 0.76 3.25 8.47 11 9.90 9.80
Other Income / (Expense), net		 -0.00 -4.20 0.01 -0.82 0.19 -0.93 -2.82 -5.52 5.65 -7.10 -2.80
Income Tax Expense		 0.00 0.01 0.01 0.02 0.06 -0.05 1.69 2.24 0.35 0.36 1.80
Net Income / (Loss) Discontinued Operations		 - - - - - - - - -15 -10 112
Preferred Stock Dividends Declared		 5.17 0.08 - - 0.00 42 8.20 8.00 8.00 8.00 8.00
Basic Earnings per Share		 ($2.44) ($0.93) ($0.34) ($0.34) ($0.55) ($1.94) ($6.18) ($0.93) ($2.21) ($2.49) $1.40
Weighted Average Basic Shares Outstanding		 5.01M 14.22M 22.96M 28.21M 33.39M 38.58M 45.93M 48.99M 48.74M 49.35M 50.07M
Diluted Earnings per Share		 ($2.44) ($0.93) ($0.34) ($0.34) ($0.55) ($1.94) ($6.18) ($0.93) ($2.21) ($2.49) $1.40
Weighted Average Diluted Shares Outstanding		 5.01M 14.22M 22.96M 28.21M 33.39M 38.58M 45.93M 48.99M 48.74M 49.35M 50.07M
Weighted Average Basic & Diluted Shares Outstanding		 5.01M 14.22M 22.96M 28.21M 33.39M 49.69M 49.69M 48.34M 48.98M 49.91M 49.86M

Quarterly Income Statements for CryoPort

This table shows CryoPort's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -15 -64 -21 -80 -1.20 -21 -14 103 -8.94 -9.96 -13
Consolidated Net Income / (Loss)		 -13 -62 -19 -78 0.81 -19 -12 105 -6.94 -7.96 -11
Net Income / (Loss) Continuing Operations		 -13 -62 -15 -76 3.92 -19 -6.74 -12 -6.70 -8.52 -9.43
Total Pre-Tax Income 		-13 -64 -15 -76 4.24 -19 -6.50 -12 -6.53 -7.40 -9.32
Total Operating Income		 -17 -70 -18 -78 -13 -14 -7.19 -9.65 -9.93 -10 -9.61
Total Gross Profit		 24 23 15 18 17 27 19 21 21 22 22
Total Revenue		 56 57 37 40 38 60 41 45 44 45 48
Total Cost of Revenue		 32 34 22 22 21 32 22 24 23 24 26
Operating Cost of Revenue		 32 34 22 22 21 32 22 24 23 24 26
Total Operating Expenses		 41 93 33 96 31 41 26 31 31 32 32
Selling, General & Admin Expense		 36 39 28 27 27 37 22 27 27 27 28
Research & Development Expense		 5.15 4.75 4.75 4.65 4.16 4.16 3.93 4.12 4.52 4.47 3.91
Total Other Income / (Expense), net		 4.11 6.12 2.58 1.68 18 -4.72 0.69 -2.09 3.40 2.64 0.29
Interest Expense		 -4.32 1.31 1.28 0.06 -16 0.64 0.58 0.62 0.53 0.63 0.43
Interest & Investment Income		 2.85 2.62 2.60 2.81 3.06 1.43 1.57 1.47 3.40 3.36 3.09
Other Income / (Expense), net		 -3.06 4.81 1.26 -1.07 -1.88 -5.51 -0.30 -2.94 0.53 -0.09 -2.37
Income Tax Expense		 0.47 -1.36 0.11 0.07 0.32 0.03 0.23 0.27 0.17 1.13 0.11
Net Income / (Loss) Discontinued Operations		 - - -3.86 -1.57 -3.12 - -5.24 117 -0.25 0.57 -1.11
Preferred Stock Dividends Declared		 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00
Basic Earnings per Share		 ($0.31) ($1.32) ($0.43) ($1.62) ($0.02) ($0.42) ($0.28) $2.05 ($0.18) ($0.19) ($0.25)
Weighted Average Basic Shares Outstanding		 48.90M 48.74M 49.02M 49.35M 49.42M 49.35M 49.95M 50.26M 50.13M 50.07M 49.90M
Diluted Earnings per Share		 ($0.31) ($1.32) ($0.43) ($1.62) ($0.02) ($0.42) ($0.28) $2.05 ($0.18) ($0.19) ($0.25)
Weighted Average Diluted Shares Outstanding		 48.90M 48.74M 49.02M 49.35M 49.42M 49.35M 49.95M 50.26M 50.13M 50.07M 49.90M
Weighted Average Basic & Diluted Shares Outstanding		 48.96M 48.98M 49.26M 49.41M 49.43M 49.91M 50.14M 50.07M 50.07M 49.86M 50.40M

Annual Cash Flow Statements for CryoPort

This table details how cash moves in and out of CryoPort's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 1.04 -0.72 11 22 9.91 -10 102 -103 9.75 -1.06 205
Net Cash From Operating Activities		 -4.13 -5.72 -3.58 -3.35 -1.32 -15 8.13 -1.85 -0.76 -16 -8.58
Net Cash From Continuing Operating Activities		 -4.13 -5.72 -3.58 -3.35 -1.32 -15 8.13 -1.85 -0.76 -16 -8.58
Net Income / (Loss) Continuing Operations		 -7.03 -13 -7.90 -9.56 -18 -33 -276 -37 -100 -115 78
Consolidated Net Income / (Loss)		 -7.03 -13 -7.90 -9.56 -18 -33 -276 -37 -100 -115 78
Depreciation Expense		 0.20 0.37 0.66 0.86 2.42 9.87 20 23 27 31 28
Amortization Expense		 1.37 0.08 0.01 0.00 0.29 0.44 1.24 2.58 2.53 1.94 1.22
Non-Cash Adjustments To Reconcile Net Income		 0.90 7.48 3.75 6.83 17 9.91 273 42 71 76 -97
Changes in Operating Assets and Liabilities, net		 0.43 -0.55 -0.10 -1.49 -2.97 -2.39 -10 -32 -2.09 -10 -19
Net Cash From Investing Activities		 -0.07 -1.07 -1.80 -13 -63 -382 -469 -60 36 177 250
Net Cash From Continuing Investing Activities		 -0.07 -1.07 -1.80 -13 -63 -382 -469 -60 36 177 250
Purchase of Property, Plant & Equipment		 -0.07 -1.06 -1.71 -2.91 -5.34 -9.47 -25 -24 -44 -20 -18
Acquisitions		 - -0.01 -0.09 -0.05 -20 -363 -5.80 -7.17 -8.21 -1.44 -1.23
Purchase of Investments		 - - 0.00 -9.92 -43 -159 -483 -164 -43 -51 0.00
Divestitures		 - - - - - - - - 0.00 0.00 210
Sale and/or Maturity of Investments		 - - - 0.00 6.00 149 44 132 130 249 60
Other Investing Activities, net		 - - - - - 0.00 0.00 3.00 0.98 0.00 0.00
Net Cash From Financing Activities		 5.23 6.06 16 39 74 386 564 -39 -24 -162 -21
Net Cash From Continuing Financing Activities		 5.23 6.06 16 39 74 386 564 -39 -24 -162 -21
Repayment of Debt		 -0.38 -0.40 -0.66 -0.30 0.00 -4.12 -3.46 -3.26 -25 -164 -15
Repurchase of Common Equity		 - - - - - 0.00 0.00 -38 0.00 0.00 -10
Other Financing Activities, net		 - 0.00 5.15 9.38 5.34 9.32 9.00 2.05 1.48 2.79 3.97
Effect of Exchange Rate Changes		 - - 0.00 -0.01 0.01 1.23 -0.99 -1.80 -1.74 -0.02 -15
Cash Interest Paid		 0.00 0.01 0.00 0.00 0.71 1.82 3.30 3.63 3.40 2.69 1.63
Cash Income Taxes Paid		 0.00 0.01 0.01 0.02 0.01 0.06 1.32 1.98 1.46 1.42 2.19

Quarterly Cash Flow Statements for CryoPort

This table details how cash moves in and out of CryoPort's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -7.84 -13 3.32 -3.21 -1.79 0.62 2.07 196 12 -5.32 22
Net Cash From Operating Activities		 -1.96 2.48 -3.27 -8.03 0.45 -5.48 -4.34 -7.35 2.19 0.92 3.74
Net Cash From Continuing Operating Activities		 -1.96 2.48 -3.27 -8.03 0.45 -5.48 -4.34 -7.35 2.19 0.92 3.74
Net Income / (Loss) Continuing Operations		 -13 -62 -19 -78 0.81 -19 -12 105 -3.25 -12 -11
Consolidated Net Income / (Loss)		 -13 -62 -19 -78 0.81 -19 -12 105 -3.25 -12 -11
Depreciation Expense		 6.91 7.45 7.47 7.56 7.84 7.89 7.65 7.30 6.42 6.36 6.40
Amortization Expense		 0.65 0.60 0.60 0.60 0.42 0.32 0.32 0.31 0.29 0.30 0.30
Non-Cash Adjustments To Reconcile Net Income		 5.96 55 5.31 70 -7.30 8.30 5.92 -111 0.05 8.19 5.87
Changes in Operating Assets and Liabilities, net		 -2.21 1.63 2.25 -8.07 -1.32 -3.32 -6.25 -9.05 -1.32 -2.28 1.71
Net Cash From Investing Activities		 19 -15 6.45 13 154 3.48 5.92 230 14 0.06 19
Net Cash From Continuing Investing Activities		 19 -15 6.45 13 154 3.48 5.92 230 14 0.06 19
Purchase of Property, Plant & Equipment		 -11 -12 -4.45 -5.42 -4.93 -5.34 -3.72 -5.86 -4.04 -4.65 -9.98
Acquisitions		 -0.23 -7.60 -0.32 -0.35 -0.46 -0.32 -0.36 -0.34 -0.24 -0.29 -0.30
Sale and/or Maturity of Investments		 30 48 25 55 160 9.14 10 26 19 5.00 29
Net Cash From Financing Activities		 -25 -0.13 0.51 -8.76 -155 2.01 -0.19 -16 -2.87 -2.15 0.09
Net Cash From Continuing Financing Activities		 -25 -0.13 0.51 -8.76 -155 2.01 -0.19 -16 -2.87 -2.15 0.09
Repayment of Debt		 -25 -0.12 -0.11 -8.77 -155 -0.13 -0.19 -15 -0.15 -0.15 -0.14
Other Financing Activities, net		 0.25 -0.00 0.62 0.01 0.02 2.14 0.00 2.95 1.02 -0.00 0.23
Effect of Exchange Rate Changes		 0.50 -0.72 -0.38 0.26 -0.52 0.61 0.68 -11 -1.23 -4.14 -0.12
Cash Interest Paid		 0.07 1.61 0.04 1.57 -0.98 2.06 0.04 0.89 0.00 0.70 0.03
Cash Income Taxes Paid		 -0.15 0.51 0.42 0.29 0.47 0.24 0.41 0.22 0.31 1.26 0.50

Annual Balance Sheets for CryoPort

This table presents CryoPort's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 2.61 8.11 20 57 136 552 1,113 1,039 958 703 765
Total Current Assets		 2.16 6.10 17 52 103 147 694 604 535 342 476
Cash & Equivalents		 1.41 4.52 15 37 47 37 139 37 46 34 250
Short-Term Investments		 - - 0.00 9.93 47 56 490 487 410 216 161
Accounts Receivable		 0.59 1.20 1.63 3.54 7.10 31 39 44 42 25 33
Inventories, net		 0.07 0.09 0.11 0.22 0.47 11 17 28 26 21 23
Prepaid Expenses		 0.10 0.29 0.52 0.75 1.10 12 8.80 9.32 10 7.94 8.42
Plant, Property, & Equipment, net		 0.31 1.65 2.51 4.36 12 30 49 64 85 80 85
Total Noncurrent Assets		 0.14 0.37 0.45 0.49 21 375 370 371 338 282 203
Goodwill		 - - - 0.00 11 145 147 151 108 21 22
Intangible Assets		 0.14 0.01 0.09 0.14 5.18 214 201 191 194 148 138
Noncurrent Deferred & Refundable Income Taxes		 - - - - - - - 0.95 0.66 0.84 1.07
Other Noncurrent Operating Assets		 0.00 0.36 0.36 0.35 4.90 16 22 28 34 42 42
Total Liabilities & Shareholders' Equity		 2.61 8.11 20 57 136 552 1,113 1,039 958 703 765
Total Liabilities		 3.02 2.43 2.38 18 9.59 170 471 483 469 302 262
Total Current Liabilities		 3.00 2.23 2.20 3.06 5.46 35 43 41 46 65 219
Short-Term Debt		 1.51 0.65 0.00 - - - 0.00 0.06 0.24 17 185
Accounts Payable		 0.76 1.16 1.20 1.71 2.50 25 29 28 27 16 15
Current Deferred Revenue		 - - 0.07 0.07 0.37 0.45 0.55 0.44 1.31 1.06 0.94
Current Employee Benefit Liabilities		 0.73 0.42 0.93 1.26 1.90 7.44 9.91 8.46 11 11 13
Other Current Liabilities		 - - - 0.02 0.69 2.29 3.60 3.85 5.66 3.71 4.56
Total Noncurrent Liabilities		 0.03 0.20 0.18 15 4.13 135 428 442 423 237 43
Long-Term Debt		 0.03 - 0.00 15 0.00 116 405 407 380 185 1.09
Capital Lease Obligations		 - - 0.00 0.03 0.01 0.11 - 0.22 0.95 0.80 0.74
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - 0.00 0.02 5.88 4.02 4.93 2.82 0.80 1.35
Other Noncurrent Operating Liabilities		 - - - 0.00 4.10 12 19 30 39 43 40
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -0.42 5.68 18 39 126 383 642 556 489 402 503
Total Preferred & Common Equity		 -0.42 5.68 18 39 126 383 642 556 489 402 503
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 2.84 10 18 26 34 42
Total Common Equity		 -0.42 5.68 18 39 126 380 632 538 463 368 460
Common Stock		 97 129 149 180 286 566 1,100 1,115 1,131 1,146 1,153
Retained Earnings		 -98 -124 -131 -141 -159 -192 -468 -543 -642 -757 -689
Accumulated Other Comprehensive Income / (Loss)		 - - 0.00 0.00 -0.05 5.38 -1.24 -35 -26 -21 -3.48

Quarterly Balance Sheets for CryoPort

This table presents CryoPort's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 1,034 1,048 1,031 1,001 943 852 702 700 774 774 764
Total Current Assets		 609 605 585 549 526 502 350 411 489 485 471
Cash & Equivalents		 31 39 67 59 50 46 45 36 243 256 273
Short-Term Investments		 499 484 437 406 399 381 228 208 183 166 131
Accounts Receivable		 44 46 43 43 41 40 43 28 33 35 39
Inventories, net		 25 26 29 29 25 24 24 23 23 23 22
Prepaid Expenses		 11 9.96 8.62 12 11 11 11 7.44 7.07 5.29 6.15
Plant, Property, & Equipment, net		 58 71 69 75 86 87 88 80 82 83 90
Total Noncurrent Assets		 367 372 376 377 331 264 263 208 203 206 203
Goodwill		 147 152 149 149 108 52 54 21 19 22 22
Intangible Assets		 192 188 195 193 190 178 176 145 144 141 139
Noncurrent Deferred & Refundable Income Taxes		 1.64 0.94 0.93 0.86 0.76 1.58 1.67 0.61 0.27 0.27 1.07
Other Noncurrent Operating Assets		 26 31 31 34 33 31 32 41 40 42 41
Total Liabilities & Shareholders' Equity		 1,034 1,048 1,031 1,001 943 852 702 700 774 774 764
Total Liabilities		 478 488 486 463 471 452 283 301 259 261 269
Total Current Liabilities		 41 42 40 45 49 60 61 74 30 31 225
Short-Term Debt		 1.01 0.06 0.06 0.07 0.11 17 18 14 0.00 0.00 186
Accounts Payable		 27 26 26 28 27 25 25 13 15 14 16
Current Deferred Revenue		 0.55 1.01 0.93 1.58 1.78 1.32 1.09 1.77 1.68 1.45 2.31
Current Employee Benefit Liabilities		 8.63 10 8.72 10 14 11 11 13 9.40 11 17
Other Current Liabilities		 3.10 4.20 4.43 4.95 5.66 5.66 6.30 4.00 4.32 4.55 4.06
Total Noncurrent Liabilities		 437 446 446 418 422 392 222 227 228 230 44
Long-Term Debt		 406 408 408 378 380 357 185 185 186 186 1.03
Capital Lease Obligations		 23 28 0.62 30 29 1.14 1.31 39 0.93 40 40
Noncurrent Deferred & Payable Income Tax Liabilities		 3.04 5.11 4.66 4.71 2.41 2.65 3.53 0.88 0.99 0.66 1.58
Other Noncurrent Operating Liabilities		 4.60 5.14 33 4.86 10 32 32 1.93 41 3.34 1.29
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Total Equity & Noncontrolling Interests		 556 561 544 538 472 400 419 399 515 513 495
Total Preferred & Common Equity		 556 561 544 538 472 400 419 399 515 513 495
Preferred Stock		 16 20 22 24 28 30 32 36 38 40 44
Total Common Equity		 539 540 522 513 444 370 386 363 477 473 451
Common Stock		 1,086 1,118 1,123 1,127 1,135 1,138 1,141 1,147 1,151 1,152 1,153
Retained Earnings		 -504 -548 -567 -580 -661 -739 -738 -769 -668 -675 -699
Accumulated Other Comprehensive Income / (Loss)		 -43 -30 -34 -34 -30 -29 -16 -16 -5.40 -4.07 -3.21

Annual Metrics And Ratios for CryoPort

This table displays calculated financial ratios and metrics derived from CryoPort's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 60,057,846.00 17,599,028.00 25,540,912.00 29,239,629.00 35,843,532.00 39,663,710.00 46,295,658.00 - - - 50,068,904.00
DEI Adjusted Shares Outstanding		 65,992,223.00 17,599,028.00 25,540,912.00 29,239,629.00 35,843,532.00 39,663,710.00 46,295,658.00 - - - 50,068,904.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.18 -0.75 -0.31 -0.33 -0.51 -1.89 -6.13 - - - 1.40
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 47.95% 95.13% 55.68% 64.18% 72.94% 131.85% 182.87% 6.59% -1.70% -2.09% 12.38%
EBITDA Growth		 1.08% -210.32% 42.38% -19.44% -71.73% -39.57% 104.03% -1,553.67% -562.98% -31.20% 88.89%
EBIT Growth		 -10.50% -131.69% 39.25% -20.16% -84.72% -76.94% 33.25% -81.22% -194.18% -25.13% 69.24%
NOPAT Growth		 -10.13% -56.73% 9.97% -9.53% -104.46% -69.79% 40.59% -78.94% -260.95% -13.64% 69.75%
Net Income Growth		 64.09% -86.61% 39.76% -20.97% -91.85% -78.34% -742.77% 86.45% -166.75% -15.23% 168.23%
EPS Growth		 49.27% 61.89% 63.44% 0.00% -61.76% -252.73% -218.56% 84.95% -137.63% -12.67% 156.22%
Operating Cash Flow Growth		 5.77% -38.55% 37.35% 6.44% 60.51% -1,022.81% 154.66% -122.78% 59.10% -2,056.27% 47.44%
Free Cash Flow Firm Growth		 -23.26% -110.13% 20.24% -40.82% -314.87% -929.82% 93.66% -75.48% -23.25% 59.47% -158.44%
Invested Capital Growth		 0.00% 738.93% 57.35% 112.10% 430.30% 1,168.20% 3.09% 5.16% -6.03% -16.86% 2.90%
Revenue Q/Q Growth		 10.18% 15.50% 10.06% 13.73% 11.69% 98.84% 3.77% 1.68% -1.31% 1.00% 2.32%
EBITDA Q/Q Growth		 -9.23% -27.86% 22.24% 2.00% 11.67% -22.46% -16.31% 11.17% -214.40% 30.35% 37.76%
EBIT Q/Q Growth		 -7.94% -24.73% 20.22% 0.88% 6.18% -49.74% 7.17% 1.41% -103.05% 24.87% 16.87%
NOPAT Q/Q Growth		 -8.09% -3.65% -3.53% 0.59% 7.05% -42.61% 7.67% -9.14% -104.47% 29.95% 6.87%
Net Income Q/Q Growth		 -7.58% -21.80% 20.32% 0.12% 6.67% -47.86% -921.53% 87.04% -113.55% 27.58% 15.87%
EPS Q/Q Growth		 59.47% 36.73% 33.33% 0.00% 6.78% -228.81% -232.26% 85.47% -95.58% 26.55% 19.66%
Operating Cash Flow Q/Q Growth		 -1.75% 8.44% -14.53% 20.43% 45.39% -236.86% 293.48% 35.97% -282.41% -95.23% 42.72%
Free Cash Flow Firm Q/Q Growth		 -20.83% -19.52% 5.84% -2.32% 3.18% -3,325.12% 93.98% 6.15% 13.98% -72,519.87% -1,002.15%
Invested Capital Q/Q Growth		 -18.66% 149.41% 20.69% 13.84% 1.31% 1,329.94% -2.86% -3.73% -13.95% -1.71% -12.49%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 29.70% 40.39% 49.91% 52.18% 51.12% 46.17% 43.38% 43.78% 42.59% 43.62% 47.14%
EBITDA Margin		 -102.43% -162.90% -60.29% -43.86% -43.55% -26.22% 0.37% -5.09% -34.34% -46.01% -6.06%
Operating Margin		 -142.12% -114.16% -66.02% -44.05% -52.07% -38.13% -8.01% -13.45% -49.37% -57.30% -20.89%
EBIT Margin		 -142.23% -168.88% -65.90% -48.23% -51.52% -39.31% -9.28% -15.77% -47.20% -60.32% -22.48%
Profit (Net Income) Margin		 -178.56% -170.77% -66.08% -48.69% -54.01% -41.54% -123.77% -15.73% -42.69% -50.25% 44.44%
Tax Burden Percent		 100.02% 100.04% 100.07% 100.21% 100.34% 99.86% 100.62% 106.38% 100.24% 101.12% -243.40%
Interest Burden Percent		 125.51% 101.08% 100.20% 100.73% 104.48% 105.81% 1,325.98% 93.77% 90.23% 82.37% 81.22%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -804.83% -237.50% -136.32% -65.07% -9.60% -3.03% -5.20% -18.90% -24.20% -9.38%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -431.66% -212.40% -121.59% -55.67% 23.21% 259.37% 3.63% 0.91% 10.38% -67.95%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 306.62% 170.47% 102.46% 42.83% -3.25% -50.76% -1.03% -0.17% -1.56% 26.70%
Return on Equity (ROE)		 1,687.95% -498.21% -67.03% -33.87% -22.24% -12.85% -53.79% -6.23% -19.06% -25.76% 17.31%
Cash Return on Invested Capital (CROIC)		 0.00% -455.08% -282.07% -208.16% -201.61% -180.36% -6.07% -10.23% -12.68% -5.79% -12.24%
Operating Return on Assets (OROA)		 -214.73% -241.97% -55.53% -24.63% -18.17% -8.99% -2.48% -3.48% -11.03% -16.59% -5.39%
Return on Assets (ROA)		 -269.58% -244.68% -55.67% -24.86% -19.05% -9.50% -33.09% -3.47% -9.98% -13.82% 10.66%
Return on Common Equity (ROCE)		 1,690.45% -498.15% -67.03% -33.87% -22.24% -12.77% -53.10% -6.09% -18.25% -24.01% 15.85%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -6.72% -20.36% -28.55% 0.00%
Net Operating Profit after Tax (NOPAT)		 -3.92 -6.14 -5.52 -6.05 -12 -21 -12 -22 -81 -92 -26
NOPAT Margin		 -99.49% -79.91% -46.22% -30.83% -36.45% -26.69% -5.61% -9.41% -34.56% -40.11% -14.62%
Net Nonoperating Expense Percent (NNEP)		 2,333.48% -373.17% -25.10% -14.74% -9.40% -32.81% -262.40% -8.84% -19.80% -34.58% 58.57%
Return On Investment Capital (ROIC_SIMPLE)		 -348.87% -96.90% -30.89% -11.36% -9.80% -4.21% -1.19% -2.32% -9.26% -15.13% -3.74%
Cost of Revenue to Revenue		 70.30% 59.61% 50.09% 47.82% 48.88% 53.83% 56.62% 56.22% 57.41% 56.38% 52.86%
SG&A Expenses to Revenue		 88.87% 83.99% 62.08% 49.93% 92.17% 72.25% 43.83% 50.60% 62.97% 65.23% 58.36%
R&D to Revenue		 8.96% 7.79% 10.09% 9.38% 11.02% 12.05% 7.57% 6.63% 7.73% 7.75% 9.67%
Operating Expenses to Revenue		 171.83% 154.55% 115.93% 96.22% 103.20% 84.30% 51.39% 57.22% 91.95% 100.92% 68.03%
Earnings before Interest and Taxes (EBIT)		 -5.60 -13 -7.88 -9.47 -17 -31 -21 -37 -110 -138 -40
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -4.03 -13 -7.21 -8.61 -15 -21 0.83 -12 -80 -105 -11
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 10.04 12.27 8.37 4.67 4.58 4.34 1.58 1.64 1.05 1.04
Price to Tangible Book Value (P/TBV)		 0.00 10.05 12.33 8.40 5.36 84.23 9.67 4.35 4.74 2.64 1.60
Price to Revenue (P/Rev)		 6.71 7.43 18.35 16.43 17.38 22.12 12.31 3.58 3.25 1.68 2.73
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.84
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 14.63%
Enterprise Value to Invested Capital (EV/IC)		 0.00 29.40 71.84 48.07 15.49 4.35 6.04 1.71 1.72 1.05 1.07
Enterprise Value to Revenue (EV/Rev)		 6.75 6.92 17.09 14.78 14.60 22.45 11.35 3.17 3.04 1.58 1.70
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 3,039.77 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 310.86 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 -3.70 0.11 0.00 0.38 0.00 0.30 0.63 0.73 0.78 0.51 0.37
Long-Term Debt to Equity		 -0.06 0.00 0.00 0.38 0.00 0.30 0.63 0.73 0.78 0.46 0.00
Financial Leverage		 -0.32 -0.71 -0.80 -0.84 -0.77 -0.14 -0.20 -0.28 -0.18 -0.15 -0.39
Leverage Ratio		 -6.26 2.04 1.20 1.36 1.17 1.35 1.63 1.80 1.91 1.86 1.62
Compound Leverage Factor		 -7.86 2.06 1.21 1.37 1.22 1.43 21.55 1.68 1.72 1.54 1.32
Debt to Total Capital		 137.10% 10.30% 0.00% 27.67% 0.01% 23.32% 38.70% 42.29% 43.80% 33.62% 27.12%
Short-Term Debt to Total Capital		 134.74% 10.30% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.03% 2.85% 26.86%
Long-Term Debt to Total Capital		 2.36% 0.00% 0.00% 27.67% 0.01% 23.32% 38.70% 42.29% 43.77% 30.77% 0.27%
Preferred Equity to Total Capital		 0.06% 0.00% 0.00% 0.00% 0.00% 0.57% 0.98% 1.90% 3.02% 5.66% 6.13%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -37.15% 89.70% 100.00% 72.33% 99.99% 76.11% 60.32% 55.81% 53.18% 60.72% 66.75%
Debt to EBITDA		 -0.38 -0.05 0.00 -1.71 0.00 -5.64 487.67 -33.72 -4.76 -1.94 -17.53
Net Debt to EBITDA		 -0.03 0.31 0.00 3.78 6.38 -1.12 -269.00 9.60 0.94 0.55 21.00
Long-Term Debt to EBITDA		 -0.01 0.00 0.00 -1.71 0.00 -5.64 487.67 -33.72 -4.76 -1.77 -0.17
Debt to NOPAT		 -0.39 -0.11 0.00 -2.44 0.00 -5.54 -32.47 -18.24 -4.73 -2.22 -7.26
Net Debt to NOPAT		 -0.03 0.63 0.00 5.37 7.62 -1.10 17.91 5.19 0.94 0.64 8.70
Long-Term Debt to NOPAT		 -0.01 0.00 0.00 -2.44 0.00 -5.54 -32.47 -18.24 -4.72 -2.03 -0.07
Altman Z-Score		 -53.23 -11.01 46.49 8.05 35.95 5.87 3.74 1.09 0.51 -0.59 0.30
Noncontrolling Interest Sharing Ratio		 -0.15% 0.01% 0.00% 0.00% 0.00% 0.56% 1.28% 2.38% 4.26% 6.80% 8.46%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.72 2.73 7.85 16.91 18.85 4.20 16.26 14.79 11.73 5.29 2.17
Quick Ratio		 0.67 2.56 7.57 16.59 18.57 3.56 15.67 13.88 10.94 4.76 2.03
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -3.92 -8.23 -6.56 -9.24 -38 -395 -25 -44 -54 -22 -34
Operating Cash Flow to CapEx		 -5,885.79% -538.03% -208.94% -115.04% -24.81% -157.00% 32.83% -7.85% -1.72% -81.05% -46.96%
Free Cash Flow to Firm to Interest Expense		 -2.74 -59.01 -418.12 -133.42 -28.04 -154.20 -0.10 -7.15 0.00 0.00 -14.24
Operating Cash Flow to Interest Expense		 -2.89 -41.02 -228.33 -48.41 -0.97 -5.81 0.03 -0.30 0.00 0.00 -3.63
Operating Cash Flow Less CapEx to Interest Expense		 -2.94 -48.64 -337.61 -90.49 -4.87 -9.51 -0.06 -4.14 0.00 0.00 -11.37
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.51 1.43 0.84 0.51 0.35 0.23 0.27 0.22 0.23 0.28 0.24
Accounts Receivable Turnover		 6.67 8.60 8.48 7.59 6.38 4.09 6.29 5.70 5.43 5.20 6.01
Inventory Turnover		 39.70 57.51 58.62 55.99 47.77 7.70 9.32 6.04 4.97 5.29 4.17
Fixed Asset Turnover		 12.78 7.86 5.75 5.71 4.19 3.76 5.63 4.21 3.14 2.63 2.13
Accounts Payable Turnover		 3.65 4.77 5.07 6.44 7.89 3.10 4.72 4.71 4.87 4.75 5.97
Days Sales Outstanding (DSO)		 54.69 42.43 43.07 48.07 57.22 89.23 58.03 64.05 67.23 70.20 60.77
Days Inventory Outstanding (DIO)		 9.19 6.35 6.23 6.52 7.64 47.43 39.15 60.44 73.43 68.99 87.53
Days Payable Outstanding (DPO)		 100.10 76.51 72.04 56.63 46.28 117.79 77.37 77.47 75.01 76.83 61.10
Cash Conversion Cycle (CCC)		 -36.21 -27.74 -22.75 -2.05 18.57 18.86 19.82 47.01 65.66 62.37 87.20
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -0.28 1.81 2.84 6.03 32 406 418 440 413 344 279
Invested Capital Turnover		 -13.91 10.07 5.14 4.42 1.79 0.36 0.54 0.55 0.55 0.60 0.64
Increase / (Decrease) in Invested Capital		 0.00 2.09 1.04 3.19 26 374 13 22 -27 -70 7.85
Enterprise Value (EV)		 27 53 204 290 496 1,766 2,526 752 709 361 299
Market Capitalization		 26 57 219 323 590 1,740 2,739 850 758 385 481
Book Value per Share		 ($0.01) $0.32 $0.70 $1.32 $3.52 $9.58 $13.64 $10.97 $9.45 $7.44 $9.19
Tangible Book Value per Share		 ($0.01) $0.32 $0.70 $1.31 $3.07 $0.52 $6.12 $3.99 $3.27 $2.94 $5.99
Total Capital		 1.12 6.33 18 53 126 499 1,047 963 870 605 690
Total Debt		 1.54 0.65 0.00 15 0.01 116 405 407 381 204 187
Total Long-Term Debt		 0.03 0.00 0.00 15 0.01 116 405 407 381 186 1.83
Net Debt		 0.13 -3.87 -15 -33 -94 23 -224 -116 -76 -58 -224
Capital Expenditures (CapEx)		 0.07 1.06 1.71 2.91 5.34 9.47 25 24 44 20 18
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.73 -0.01 0.05 1.46 3.21 19 22 40 33 33 31
Debt-free Net Working Capital (DFNWC)		 0.68 4.52 15 49 98 112 651 563 490 294 442
Net Working Capital (NWC)		 -0.83 3.87 15 49 98 112 651 563 490 277 257
Net Nonoperating Expense (NNE)		 3.11 6.98 2.37 3.50 5.96 12 263 15 19 23 -104
Net Nonoperating Obligations (NNO)		 0.13 -3.87 -15 -33 -94 23 -224 -116 -76 -58 -224
Total Depreciation and Amortization (D&A)		 1.57 0.46 0.67 0.86 2.70 10 21 25 30 33 29
Debt-free, Cash-free Net Working Capital to Revenue		 -18.49% -0.10% 0.46% 7.41% 9.45% 23.91% 9.92% 16.88% 14.14% 14.23% 17.71%
Debt-free Net Working Capital to Revenue		 17.22% 58.83% 126.29% 248.20% 287.27% 142.49% 292.38% 237.44% 209.96% 128.84% 251.12%
Net Working Capital to Revenue		 -21.21% 50.34% 126.29% 248.20% 287.27% 142.49% 292.38% 237.41% 209.86% 121.29% 145.96%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($2.22) $0.00 ($0.34) ($0.34) ($0.55) ($1.94) ($6.18) ($0.93) ($2.21) ($2.49) $1.40
Adjusted Weighted Average Basic Shares Outstanding		 5.52M 0.00 27.34M 30.44M 37.64M 45.58M 45.93M 48.99M 48.74M 49.35M 50.07M
Adjusted Diluted Earnings per Share		 ($2.22) $0.00 ($0.34) ($0.34) ($0.55) ($1.94) ($6.19) ($0.93) ($2.21) ($2.49) $1.40
Adjusted Weighted Average Diluted Shares Outstanding		 5.52M 0.00 27.34M 30.44M 37.64M 45.58M 45.93M 48.99M 48.74M 49.35M 50.07M
Adjusted Basic & Diluted Earnings per Share		 ($2.22) $0.00 ($0.34) ($0.34) ($0.55) ($1.94) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 5.50M 0.00 22.96M 28.21M 33.39M 38.58M 49.69M 48.34M 48.98M 49.91M 49.86M
Normalized Net Operating Profit after Tax (NOPAT)		 -3.92 -6.14 -5.52 -6.05 -12 -21 -12 -22 -46 -47 -26
Normalized NOPAT Margin		 -99.49% -79.91% -46.22% -30.83% -36.45% -26.69% -5.61% -9.41% -19.68% -20.55% -14.62%
Pre Tax Income Margin		 -178.52% -170.70% -66.03% -48.59% -53.83% -41.60% -123.02% -14.79% -42.59% -49.69% -18.26%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -3.92 -93.02 -502.02 -136.69 -12.79 -12.09 -0.08 -6.09 0.00 0.00 -16.78
NOPAT to Interest Expense		 -2.74 -44.01 -352.05 -87.38 -9.05 -8.21 -0.05 -3.64 0.00 0.00 -10.91
EBIT Less CapEx to Interest Expense		 -3.97 -100.64 -611.30 -178.77 -16.70 -15.78 -0.18 -9.93 0.00 0.00 -24.51
NOPAT Less CapEx to Interest Expense		 -2.79 -51.64 -461.33 -129.46 -12.95 -11.90 -0.15 -7.48 0.00 0.00 -18.65
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -101.68% 0.00% 0.00% 12.79%

Quarterly Metrics And Ratios for CryoPort

This table displays calculated financial ratios and metrics derived from CryoPort's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - 49,910,391.00 50,137,218.00 50,066,968.00 50,068,904.00 49,856,135.00
DEI Adjusted Shares Outstanding		 - - - - - - 49,910,391.00 50,137,218.00 50,066,968.00 50,068,904.00 49,856,135.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - -0.28 2.06 -0.18 -0.20 -0.25
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -7.12% -5.13% -13.09% 1.01% 0.90% 3.97% 10.05% 14.47% 15.44% 9.64% 16.47%
EBITDA Growth		 -4,307.46% -2,280.38% -1,281.29% -518.58% 21.19% 80.31% 105.77% 92.98% 61.50% 65.13% -1,219.49%
EBIT Growth		 -225.48% -608.68% -230.17% -322.09% 9.65% 70.12% 53.88% 84.09% 38.38% 44.27% -59.89%
NOPAT Growth		 -116.70% -533.18% -111.86% -332.18% 23.17% 80.06% 58.91% 87.63% 43.89% 21.29% -33.64%
Net Income Growth		 -149.61% -561.18% -238.98% -324.89% 106.07% 70.06% 36.59% 234.87% -962.48% 57.41% 11.99%
EPS Growth		 -106.67% -450.00% -168.75% -285.71% 93.55% 68.18% 34.88% 226.54% -800.00% 54.76% 10.71%
Operating Cash Flow Growth		 -299.49% -32.07% -217.70% -97.95% 122.82% -320.79% -32.99% 8.47% 389.49% 116.77% 186.02%
Free Cash Flow Firm Growth		 -11.13% 23.51% 152.33% 221.72% 444.47% 367.43% 302.55% 43.73% -79.35% -111.12% -110.01%
Invested Capital Growth		 5.14% -6.03% -8.61% -22.33% -27.21% -16.86% -27.70% -20.73% -8.98% 2.90% 1.52%
Revenue Q/Q Growth		 -1.52% 1.96% -4.66% 5.50% -1.62% 5.06% -0.99% 10.76% -2.69% 2.75% 5.17%
EBITDA Q/Q Growth		 -6.35% -359.31% 79.18% -508.10% 86.45% -14.77% 104.75% -1,155.30% 45.83% -28.50% -52.41%
EBIT Q/Q Growth		 -4.90% -225.81% 69.35% -302.91% 77.55% -7.74% 58.72% -67.97% 25.27% -7.56% -18.42%
NOPAT Q/Q Growth		 7.76% -313.22% 69.54% -272.29% 83.60% -7.23% 43.55% -34.13% -2.93% -1.00% 4.16%
Net Income Q/Q Growth		 27.71% -370.19% 69.71% -312.75% 101.03% -2,420.12% 35.85% 977.89% -106.60% -14.58% -32.55%
EPS Q/Q Growth		 26.19% -325.81% 67.42% -276.74% 98.77% -2,000.00% 33.33% 832.14% -108.78% -5.56% -31.58%
Operating Cash Flow Q/Q Growth		 51.68% 226.70% -231.55% -145.79% 105.57% -1,325.95% 20.77% -69.16% 129.79% -58.00% 306.42%
Free Cash Flow Firm Q/Q Growth		 3.89% 36.55% 215.57% 72.70% 171.98% -50.74% -14.12% -43.00% -62.68% -160.86% 22.67%
Invested Capital Q/Q Growth		 7.08% -13.95% 4.74% -19.52% 0.35% -1.71% 15.65% -11.77% 15.24% -12.49% 14.10%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 43.21% 40.62% 39.89% 43.73% 44.80% 45.83% 45.42% 47.03% 48.21% 47.77% 45.85%
EBITDA Margin		 -22.10% -99.56% -21.75% -125.34% -17.26% -18.86% 1.15% -10.96% -6.10% -7.63% -11.05%
Operating Margin		 -30.11% -122.02% -38.98% -137.56% -28.99% -23.40% -17.53% -21.23% -22.45% -22.07% -20.11%
EBIT Margin		 -35.56% -113.62% -36.53% -139.50% -31.84% -32.65% -18.26% -27.69% -21.27% -22.26% -25.07%
Profit (Net Income) Margin		 -23.63% -108.96% -34.61% -135.40% 1.42% -31.37% -29.19% 231.40% -15.70% -17.50% -22.06%
Tax Burden Percent		 103.68% 97.87% 101.15% 100.49% 55.36% 100.16% 184.21% -895.91% 106.31% 107.57% 113.08%
Interest Burden Percent		 64.09% 97.99% 93.67% 96.59% -8.06% 95.93% 86.79% 93.26% 69.43% 73.09% 77.82%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 44.64% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -10.63% -46.70% -13.55% -54.51% -8.74% -9.88% -5.28% -7.91% -8.10% -9.91% -8.17%
ROIC Less NNEP Spread (ROIC-NNEP)		 -8.79% -32.64% -7.20% -23.93% -24.45% 3.45% 5.83% -84.87% -8.11% -9.39% -5.27%
Return on Net Nonoperating Assets (RNNOA)		 1.25% 5.99% 0.88% 3.73% 3.22% -0.52% -0.84% 26.97% 2.30% 3.69% 1.55%
Return on Equity (ROE)		 -9.38% -40.72% -12.67% -50.78% -5.52% -10.40% -6.12% 19.06% -5.81% -6.22% -6.62%
Cash Return on Invested Capital (CROIC)		 -13.42% -12.68% -10.52% -7.76% -0.01% -5.79% 11.25% 13.50% 1.12% -12.24% -10.22%
Operating Return on Assets (OROA)		 -8.26% -26.55% -8.26% -33.43% -8.46% -8.98% -3.57% -5.66% -4.96% -5.34% -6.27%
Return on Assets (ROA)		 -5.49% -25.46% -7.82% -32.45% 0.38% -8.63% -5.71% 47.31% -3.66% -4.20% -5.52%
Return on Common Equity (ROCE)		 -9.03% -38.98% -12.07% -47.95% -5.19% -9.69% -5.66% 17.63% -5.35% -5.70% -6.02%
Return on Equity Simple (ROE_SIMPLE)		 -8.68% 0.00% -23.91% -43.13% -37.86% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -12 -49 -15 -55 -9.09 -9.75 -5.04 -6.75 -6.95 -7.02 -6.73
NOPAT Margin		 -21.08% -85.42% -27.29% -96.29% -16.05% -16.38% -12.27% -14.86% -15.72% -15.45% -14.08%
Net Nonoperating Expense Percent (NNEP)		 -1.84% -14.07% -6.34% -30.59% 15.71% -13.33% -11.11% 76.96% 0.01% -0.53% -2.90%
Return On Investment Capital (ROIC_SIMPLE)		 -1.25% -5.62% -1.69% -7.15% -1.46% -1.61% -0.79% -0.96% -0.94% -1.02% -0.93%
Cost of Revenue to Revenue		 56.79% 59.38% 60.11% 56.27% 55.20% 54.17% 54.58% 52.97% 51.79% 52.23% 54.16%
SG&A Expenses to Revenue		 64.15% 67.79% 70.16% 62.44% 66.45% 62.25% 53.37% 59.20% 60.44% 60.01% 57.78%
R&D to Revenue		 9.17% 8.29% 8.70% 8.07% 7.34% 6.98% 9.59% 9.06% 10.23% 9.83% 8.17%
Operating Expenses to Revenue		 73.32% 162.65% 78.87% 181.29% 73.79% 69.23% 62.95% 68.26% 70.66% 69.84% 65.96%
Earnings before Interest and Taxes (EBIT)		 -20 -65 -20 -80 -18 -19 -7.49 -13 -9.41 -10 -12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -12 -57 -12 -72 -9.78 -11 0.47 -4.98 -2.70 -3.47 -5.28
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.31 1.64 1.95 0.92 1.04 1.05 0.84 0.78 1.00 1.04 0.92
Price to Tangible Book Value (P/TBV)		 3.91 4.74 5.93 2.45 2.56 2.64 1.55 1.19 1.53 1.60 1.42
Price to Revenue (P/Rev)		 2.84 3.25 3.85 1.51 1.77 1.68 1.89 2.25 2.76 2.73 2.26
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.56 7.97 6.84 5.75
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 18.00% 12.55% 14.63% 17.38%
Enterprise Value to Invested Capital (EV/IC)		 1.33 1.72 1.98 0.92 1.04 1.05 1.07 0.63 1.01 1.07 0.88
Enterprise Value to Revenue (EV/Rev)		 2.70 3.04 3.80 1.41 1.61 1.58 2.08 1.04 1.86 1.70 1.53
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 1,535.58 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 7.97 4.11 85.86 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.76 0.78 0.87 0.94 0.49 0.51 0.60 0.36 0.44 0.37 0.46
Long-Term Debt to Equity		 0.76 0.78 0.87 0.89 0.44 0.46 0.56 0.36 0.44 0.00 0.08
Financial Leverage		 -0.14 -0.18 -0.12 -0.16 -0.13 -0.15 -0.14 -0.32 -0.28 -0.39 -0.29
Leverage Ratio		 1.86 1.91 1.93 1.99 1.78 1.86 1.89 1.78 1.58 1.62 1.64
Compound Leverage Factor		 1.19 1.87 1.81 1.93 -0.14 1.79 1.64 1.66 1.10 1.19 1.27
Debt to Total Capital		 43.19% 43.80% 46.43% 48.41% 32.74% 33.62% 37.44% 26.60% 30.60% 27.12% 31.39%
Short-Term Debt to Total Capital		 0.01% 0.03% 0.01% 2.24% 2.82% 2.85% 2.27% 0.00% 0.00% 26.86% 25.72%
Long-Term Debt to Total Capital		 43.19% 43.77% 46.42% 46.17% 29.92% 30.77% 35.17% 26.60% 30.60% 0.27% 5.67%
Preferred Equity to Total Capital		 2.57% 3.02% 3.21% 3.90% 5.19% 5.66% 5.69% 5.45% 5.45% 6.13% 6.14%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 54.24% 53.18% 50.36% 47.68% 62.07% 60.72% 56.87% 67.95% 63.95% 66.75% 62.48%
Debt to EBITDA		 -16.05 -4.76 -4.40 -2.45 -1.35 -1.94 -2.73 -8.70 -13.20 -17.53 -13.78
Net Debt to EBITDA		 2.24 0.94 0.42 0.34 0.46 0.55 0.06 11.15 11.37 21.00 10.79
Long-Term Debt to EBITDA		 -16.04 -4.76 -4.40 -2.33 -1.23 -1.77 -2.56 -8.70 -13.20 -0.17 -2.49
Debt to NOPAT		 -10.37 -4.73 -4.63 -2.86 -1.56 -2.22 -3.06 -6.21 -8.18 -7.26 -8.25
Net Debt to NOPAT		 1.45 0.94 0.44 0.39 0.53 0.64 0.07 7.95 7.05 8.70 6.45
Long-Term Debt to NOPAT		 -10.37 -4.72 -4.62 -2.73 -1.42 -2.03 -2.88 -6.21 -8.18 -0.07 -1.49
Altman Z-Score		 0.83 0.66 0.90 -0.19 0.11 -0.04 -0.16 0.53 0.76 0.43 0.21
Noncontrolling Interest Sharing Ratio		 3.71% 4.26% 4.70% 5.56% 5.91% 6.80% 7.41% 7.49% 7.79% 8.46% 9.01%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 12.23 11.73 10.73 8.38 5.70 5.29 5.56 16.24 15.77 2.17 2.09
Quick Ratio		 11.32 10.94 10.00 7.80 5.15 4.76 3.68 15.24 14.84 2.03 1.97
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -35 -22 26 45 122 60 115 65 24 -15 -11
Operating Cash Flow to CapEx		 -17.39% 20.71% -73.39% -148.04% 9.07% -102.54% -116.63% -125.38% 54.16% 19.76% 37.42%
Free Cash Flow to Firm to Interest Expense		 0.00 -17.16 19.35 677.63 0.00 94.22 197.05 105.96 46.46 -23.46 -26.62
Operating Cash Flow to Interest Expense		 0.00 1.90 -2.44 -121.59 0.00 -8.62 -7.45 -11.89 4.16 1.45 8.65
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -7.28 -5.77 -203.73 0.00 -17.02 -13.83 -21.36 -3.52 -5.88 -14.46
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.23 0.23 0.23 0.24 0.27 0.28 0.20 0.20 0.23 0.24 0.25
Accounts Receivable Turnover		 5.43 5.43 5.18 5.42 5.25 5.20 4.61 4.52 4.39 6.01 5.43
Inventory Turnover		 5.00 4.97 5.09 5.00 4.96 5.29 3.61 3.83 3.90 4.17 4.29
Fixed Asset Turnover		 3.58 3.14 2.86 2.90 2.78 2.63 1.93 1.98 2.01 2.13 2.15
Accounts Payable Turnover		 4.85 4.87 4.92 5.15 4.92 4.75 4.28 4.52 4.67 5.97 6.58
Days Sales Outstanding (DSO)		 67.21 67.23 70.42 67.33 69.48 70.20 79.16 80.75 83.07 60.77 67.21
Days Inventory Outstanding (DIO)		 73.06 73.43 71.76 72.98 73.64 68.99 101.11 95.31 93.66 87.53 85.18
Days Payable Outstanding (DPO)		 75.33 75.01 74.17 70.89 74.21 76.83 85.34 80.84 78.08 61.10 55.50
Cash Conversion Cycle (CCC)		 64.94 65.66 68.01 69.42 68.90 62.37 94.93 95.23 98.66 87.20 96.89
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 480 413 433 348 350 344 313 276 318 279 318
Invested Capital Turnover		 0.50 0.55 0.50 0.57 0.54 0.60 0.43 0.53 0.52 0.64 0.58
Increase / (Decrease) in Invested Capital		 23 -27 -41 -100 -131 -70 -120 -72 -31 7.85 4.77
Enterprise Value (EV)		 637 709 856 319 364 361 334 173 320 299 280
Market Capitalization		 670 758 867 340 401 385 303 374 475 481 413
Book Value per Share		 $10.50 $9.45 $9.06 $7.51 $7.82 $7.44 $7.26 $9.52 $9.45 $9.19 $9.04
Tangible Book Value per Share		 $3.51 $3.27 $2.99 $2.82 $3.17 $2.94 $3.93 $6.28 $6.18 $5.99 $5.81
Total Capital		 946 870 881 776 622 605 637 702 740 690 721
Total Debt		 409 381 409 375 204 204 239 187 226 187 226
Total Long-Term Debt		 409 381 409 358 186 186 224 187 226 1.83 41
Net Debt		 -57 -76 -39 -52 -69 -58 -5.36 -239 -195 -224 -177
Capital Expenditures (CapEx)		 11 12 4.45 5.42 4.93 5.34 3.72 5.86 4.04 4.65 9.98
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 38 33 28 32 34 33 108 33 33 31 28
Debt-free Net Working Capital (DFNWC)		 504 490 477 460 306 294 352 459 454 442 431
Net Working Capital (NWC)		 504 490 477 442 289 277 337 459 454 257 246
Net Nonoperating Expense (NNE)		 1.43 13 4.00 23 -9.90 8.93 6.95 -112 -0.01 0.93 3.81
Net Nonoperating Obligations (NNO)		 -57 -76 -39 -52 -69 -58 -86 -239 -195 -224 -177
Total Depreciation and Amortization (D&A)		 7.56 8.05 8.07 8.16 8.26 8.21 7.97 7.61 6.71 6.65 6.70
Debt-free, Cash-free Net Working Capital to Revenue		 16.27% 14.14% 12.57% 14.35% 14.95% 14.23% 67.09% 20.07% 19.04% 17.71% 15.08%
Debt-free Net Working Capital to Revenue		 213.37% 209.96% 211.90% 203.68% 135.54% 128.84% 219.12% 276.27% 263.73% 251.12% 235.72%
Net Working Capital to Revenue		 213.34% 209.86% 211.85% 195.96% 127.77% 121.29% 210.10% 276.27% 263.73% 145.96% 134.29%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.31) ($1.32) ($0.43) ($1.62) ($0.02) ($0.42) ($0.28) $2.05 ($0.18) ($0.19) ($0.25)
Adjusted Weighted Average Basic Shares Outstanding		 48.90M 48.74M 49.02M 49.35M 49.42M 49.35M 49.95M 50.26M 50.13M 50.07M 49.90M
Adjusted Diluted Earnings per Share		 ($0.31) ($1.32) ($0.43) ($1.62) ($0.02) ($0.42) ($0.28) $2.05 ($0.18) ($0.19) ($0.25)
Adjusted Weighted Average Diluted Shares Outstanding		 48.90M 48.74M 49.02M 49.35M 49.42M 49.35M 49.95M 50.26M 50.13M 50.07M 49.90M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 48.96M 48.98M 49.26M 49.41M 49.43M 49.91M 50.14M 50.07M 50.07M 49.86M 50.40M
Normalized Net Operating Profit after Tax (NOPAT)		 -12 -14 -15 -11 -9.09 -9.75 -5.04 -6.75 -6.95 -7.02 -6.73
Normalized NOPAT Margin		 -21.08% -24.82% -27.29% -18.74% -16.05% -16.38% -12.27% -14.86% -15.72% -15.45% -14.08%
Pre Tax Income Margin		 -22.79% -111.33% -34.22% -134.74% 2.57% -31.32% -15.85% -25.83% -14.77% -16.27% -19.51%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 -49.81 -14.90 -1,217.41 0.00 -30.56 -12.85 -20.37 -17.88 -15.96 -27.74
NOPAT to Interest Expense		 0.00 -37.45 -11.13 -840.30 0.00 -15.33 -8.64 -10.93 -13.22 -11.08 -15.58
EBIT Less CapEx to Interest Expense		 0.00 -58.99 -18.23 -1,299.55 0.00 -38.97 -19.24 -29.85 -25.56 -23.29 -50.84
NOPAT Less CapEx to Interest Expense		 0.00 -46.63 -14.46 -922.43 0.00 -23.74 -15.02 -20.41 -20.90 -18.41 -38.68
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.65% 11.84% 12.79% 0.00%

Financials Breakdown Chart

Key Financial Trends

Cryoport (NASDAQ: CYRX) showed a meaningful rebound in Q1 2026, but the business is still not consistently profitable. Revenue rose year over year, operating cash flow turned solidly positive, and the balance sheet remains flush with cash and investments. At the same time, margins are still under pressure, debt is elevated, and the company continues to post net losses.

  • Revenue grew year over year. Q1 2026 revenue was $47.8 million, up from $41.0 million in Q1 2025, showing continued top-line growth.
  • Operating cash flow improved sharply. CryoPort generated $3.7 million in operating cash flow in Q1 2026, versus a cash outflow of $4.3 million in Q1 2025.
  • The balance sheet remains liquid. As of Q1 2026, cash and equivalents were $272.9 million and short-term investments were $130.7 million, giving the company substantial liquidity.
  • Investments boosted cash generation. The company also realized $29.0 million from sale/maturity of investments in the quarter, helping drive a $22.4 million increase in cash and equivalents.
  • Gross profit improved modestly. Gross profit rose to $21.9 million from $18.6 million a year ago, supported by higher revenue.
  • Operating expenses remain high relative to revenue. SG&A was $27.6 million and R&D was $3.9 million in Q1 2026, which kept the company in operating loss territory.
  • Profitability is still negative. CryoPort reported a net loss of $10.5 million in Q1 2026, essentially unchanged from the $10.5 million loss in Q1 2025.
  • Preferred stock dividends continue to weigh on common shareholders. The company recorded $2.0 million in preferred dividends, pushing loss attributable to common shareholders to $12.5 million.
  • Operating margin remains weak. Q1 2026 operating loss was $9.6 million on $47.8 million of revenue, indicating the company is still not close to breakeven at the operating level.
  • Leverage is still significant. Total liabilities were $268.6 million, including $185.5 million of short-term debt and $1.0 million of long-term debt, plus $39.9 million of capital lease obligations.

Longer-term trend: CryoPort’s quarterly results over the last several years show a company that has moved from periods of extreme volatility to a more stable, but still unprofitable, operating profile. Revenue has generally trended higher versus early 2024, and cash on hand has stayed strong, but large swings in net income have been driven by investment activity, asset adjustments, and discontinued operations. The key question for investors is whether the company can convert its healthier liquidity position and modest revenue growth into sustained operating profitability.

Bottom line: CYRX’s Q1 2026 report is encouraging from a cash flow and liquidity standpoint, but investors should still view the stock as a turnaround story rather than a proven earnings compounder.

06/12/26 11:55 PM ETAI Generated. May Contain Errors.

CryoPort Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CryoPort's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

CryoPort's net income appears to be on an upward trend, with a most recent value of $78.30 million in 2025, falling from -$7.03 million in 2015. The previous period was -$114.76 million in 2024. View CryoPort's forecast to see where analysts expect CryoPort to go next.

CryoPort's total operating income in 2025 was -$36.81 million, based on the following breakdown:
  • Total Gross Profit: $83.05 million
  • Total Operating Expenses: $119.86 million

Over the last 10 years, CryoPort's total revenue changed from $3.94 million in 2015 to $176.18 million in 2025, a change of 4,376.8%.

CryoPort's total liabilities were at $262.35 million at the end of 2025, a 13.0% decrease from 2024, and a 8,578.6% increase since 2015.

In the past 10 years, CryoPort's cash and equivalents has ranged from $1.41 million in 2015 to $250.49 million in 2025, and is currently $250.49 million as of their latest financial filing in 2025.

Over the last 10 years, CryoPort's book value per share changed from -0.01 in 2015 to 9.19 in 2025, a change of -133,355.1%.


Related Companies

Financial statements for NASDAQ:CYRX last updated on 5/20/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...
InvestPub | Sponsoredtc pixel
THIS billionaire could hold your financial fate
60-year Wall Street veteran Marc Chaikin is issuing an urgent warning about the billionaire behind an AI lab t...
Chaikin Analytics | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX is set to go public as soon as June 11, with OpenAI and Anthropic likely to follow. Whitney Tilson - Ha...
Stansberry Research | Sponsoredtc pixel
Tesla. SolarCity. Twitter. This $4 stock is next.
Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...
Behind the Markets | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel